BE876382A - Procede pour causer de l'anorexie par administration buccale de naltrexone ou d'un sel de celle-ci - Google Patents

Procede pour causer de l'anorexie par administration buccale de naltrexone ou d'un sel de celle-ci

Info

Publication number
BE876382A
BE876382A BE0/195262A BE195262A BE876382A BE 876382 A BE876382 A BE 876382A BE 0/195262 A BE0/195262 A BE 0/195262A BE 195262 A BE195262 A BE 195262A BE 876382 A BE876382 A BE 876382A
Authority
BE
Belgium
Prior art keywords
naltrexone
emi
anorexia
salt
appetite
Prior art date
Application number
BE0/195262A
Other languages
English (en)
French (fr)
Inventor
D Smith
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of BE876382A publication Critical patent/BE876382A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/195262A 1978-05-19 1979-05-18 Procede pour causer de l'anorexie par administration buccale de naltrexone ou d'un sel de celle-ci BE876382A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90782578A 1978-05-19 1978-05-19

Publications (1)

Publication Number Publication Date
BE876382A true BE876382A (fr) 1979-11-19

Family

ID=25424700

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/195262A BE876382A (fr) 1978-05-19 1979-05-18 Procede pour causer de l'anorexie par administration buccale de naltrexone ou d'un sel de celle-ci

Country Status (3)

Country Link
JP (1) JPS55382A (ja)
BE (1) BE876382A (ja)
ZA (1) ZA792424B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100390A3 (en) * 2001-06-11 2004-04-22 Cpd Llc Improved method of treating the syndrome of coronary heart disease risk factors in humans
US10034871B2 (en) 2014-11-07 2018-07-31 Regents Of The University Of Minnesota Salts and compositions useful for treating disease

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551365A (en) * 1981-10-23 1985-11-05 Composite Container Corporation Rigid coextruded sheet and container

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100390A3 (en) * 2001-06-11 2004-04-22 Cpd Llc Improved method of treating the syndrome of coronary heart disease risk factors in humans
US10034871B2 (en) 2014-11-07 2018-07-31 Regents Of The University Of Minnesota Salts and compositions useful for treating disease

Also Published As

Publication number Publication date
ZA792424B (en) 1980-05-28
JPS55382A (en) 1980-01-05

Similar Documents

Publication Publication Date Title
LU81294A1 (fr) Procede pour causer de l'anorecie par administration buccale de naltrexone ou d'un sel de celle-ci
CN105250285B (zh) 预防和治疗成瘾的组合物和方法
EP3941904A1 (en) Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine
US20080319000A1 (en) Use of 3,1IB-Cis-Dihydrotetrabenazine for the Treatment of Symptoms of Huntingtons Disease
JP2002532393A (ja) エキソ−ｒ−メカミラミン製剤および治療におけるその使用
JPH0564930B2 (ja)
CA2691812A1 (en) A drug demonstrating anxiolytic effect based on hydrogenated pyrido (4,3-b) indoles, its pharmacological compound and application method
MXPA03011314A (es) Formulacion farmaceutica para la administracion eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina y sus derivados y pro-farmacos de los mismos.
RU2232016C2 (ru) Изовалерамид-антиспастическое и противосудорожное средство, экстракт из растения семейства valerianaceae или хмеля - средство для лечения симптома спастичности и способ устранения этого симптома, способ лечения патологии, снимаемой центрально-опосредованным снижением мышечного тонуса
Jones et al. Why do cholestatic patients itch?
JPH0344324A (ja) 性機能賦活剤
WO1997000692A1 (en) ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER
BE876382A (fr) Procede pour causer de l'anorexie par administration buccale de naltrexone ou d'un sel de celle-ci
JP5106809B2 (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品
IL305528A (en) Combinations of opioids and acylethnoamines
JPH06172187A (ja) 筋ジストロフィー症治療薬
WO2011150175A2 (en) Compositions and methods for pain reduction
US20130209581A1 (en) Iodinated activated charcoal for treating symptoms of depression
JP6864964B2 (ja) 経口睡眠改善剤
JP2004531533A (ja) 向精神物質による中毒に起因する、中枢神経系の病態の処置のためのガランタミンの使用
US20070028930A1 (en) Active agent and formulations to minimize or alleviate bladder urgency and irritation and/or to enhance sexual function
US7288269B2 (en) Asafetida extract as medicine for abstinence of drugs
CH640137A5 (fr) Composition pharmaceutique contenant de la s-adenosyl-l-homocysteine.
TW202010496A (zh) 双那布扶林己二酸酯和乙醯胺酚的藥物製劑及治療疼痛的方法
JP2004526791A (ja) 向精神薬による中毒のもたらす中枢神経系の症状の処置のためのデオキシペガニンの使用

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: E.I. DU PONT DE NEMOURS AND CY

Effective date: 19850518